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Vaccinia virus genes A18 and G2 affect the elongation and termination of postreplicative viral gene transcription in
opposite ways. Viruses with mutations in gene A18 produce abnormally long transcripts, indicating that A18 is a negative
transcription elongation factor. Viruses containing mutations in gene G2 produce transcripts that are abnormally short,
truncated specifically from their 39 ends, indicating that G2 is a positive transcription elongation factor. Despite the fact that
both A18 and G2 are essential genes, A18-G2 double-mutant viruses are viable, presumably because the effects of the
mutations are mutually compensatory. In addition, the anti-poxviral drug isatin-b-thiosemicarbazone (IBT) seems to enhance
elongation during a vaccinia infection: IBT treatment of a wildtype vaccinia infection induces a phenotype identical to an A18
mutant infection, and G2 mutant viruses are dependent on IBT for growth, presumably because IBT restores the G2 mutant
truncated transcripts to a normal length. These observations inspire two independent genetic selections that have now been
used to identify an additional vaccinia gene, J3, that regulates postreplicative transcription elongation. In the first selection,
a single virus that contains an extragenic suppressor of the A18 temperature-sensitive mutant, Cts23, was isolated. In the
second selection, several spontaneous IBT-dependent (IBTd) mutant viruses were isolated and characterized genetically.
Marker rescue mapping and DNA sequence analysis show that the extragenic suppressor of Cts23 contains a point mutation
in the J3 gene, while each of seven new IBTd mutants contains null mutations in the J3 gene. The J3 protein has previously
been identified as a (nucleoside-29-O-)-methyltransferase and as a processivity subunit for the heterodimeric viral poly(A)
polymerase. The nature of the two independent selections used to isolate the J3 mutants strongly suggests that the J3 protein
serves as a positive postreplicative transcription elongation factor during a normal virus infection. © 2000 Academic Press
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AINTRODUCTION
Vaccinia is a member of the orthopox virus family. It
encodes approximately 200 genes on a 192-kb double-
stranded DNA genome that replicates strictly in the cy-
toplasm of host cells. Due to the cytoplasmic location of
its replication cycle, vaccinia must encode its own mul-
tisubunit RNA polymerase and almost all of the transcrip-
tion factors required to carry out distinct early, interme-
diate, and late stages of gene expression (Moss, 1996).
Historically, vaccinia has served as an excellent model
for studying the essentials of eukaryotic transcription
(Traktman, 1990).
Intermediate and late (together termed “postreplica-
tive”) vaccinia gene transcription is notably different from
the transcription of early genes specifically with respect
to the process of termination. Early termination is cata-
1 Present address: Department of Cancer Biology, Research Institute,
he Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH
4195.
2 To whom correspondence and reprint requests should be ad-
dressed at Department of Molecular Genetics and Microbiology, P.O.h
t
Box 100266, University of Florida, Gainesville, FL 32610. Fax: (352)
392-3133. E-mail: condit@mgm.ufl.edu.
345lyzed by the virus coded capping enzyme (VTF) (Shuman
et al., 1987), along with a viral DNA-dependent ATPase
(NPH I) (Christen et al., 1998; Deng and Shuman, 1998), in
response to a cis-acting termination sequence, U5NU,
ocated 30–50 nucleotides upstream from the 39 end of
he nascent early mRNA (Shuman and Moss, 1988; Yuen
nd Moss, 1987). Through this termination mechanism,
he polymerase produces from early genes a population
f transcripts that is characteristically homogeneous in
ength. By contrast, the polymerase transcribing an inter-
ediate or late gene reads through U5NU early termina-
ion sequences and terminates in a seemingly random
ashion to produce a population of transcripts that is very
eterogeneous in length (Mahr and Roberts, 1984). No
is-acting termination sequences have yet been identi-
ied for intermediate or late genes.
Previous genetic and biochemical evidence has sug-
ested that two different vaccinia genes, A18 and G2,
ffect the termination and elongation of postreplicative
ene transcripts in opposite ways. The 56-kDa A18 pro-
ein has been characterized as a DNA-dependent
TPase (Bayliss and Condit, 1995) and a 39-59 DNA
elicase (Simpson and Condit, 1995). Viruses with muta-
ions in A18 produce abnormally long transcripts that
0042-6822/00 $35.00
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346 LATNER ET AL.(Xiang et al., 1998), when transcribed from opposing
romoters, can hybridize to one another, forming double-
tranded RNA, which in turn induces the cellular 2-5A
athway, leading ultimately to RNase L catalyzed RNA
egradation and abortion of the infection (Bayliss and
ondit, 1993; Cohrs et al., 1989; Pacha and Condit, 1985).
onsistent with this in vivo phenotype, it has been re-
cently demonstrated using an in vitro transcription assay
that the A18 protein is required for release of nascent
transcripts from an elongation complex, showing that
A18 serves as a transcript release factor (Lackner and
Condit, 2000). In contrast to A18 mutants, viruses con-
taining mutations in the gene G2 produce intermediate
and late transcripts that are shorter than wildtype tran-
scripts and that are specifically truncated from their 39
ends (Black and Condit, 1996). As a result, G2 mutants
produce reduced quantities of large proteins at late
times during infection. These findings suggest that the
26-kDa G2 protein, which has no significant homology to
any known protein, serves as a postreplicative positive
transcription elongation factor.
Viruses with G2 mutations have a phenotype that is
selectable by two distinct methods. First, G2 null mutants
are extragenic suppressors of temperature-sensitive mu-
tations in gene A18 (Condit et al., 1996). The suppression
follows logically from the complementary nature of the
individual mutant phenotypes: 39 truncation of RNAs re-
sulting from a G2 mutation should compensate for the
read-through transcription caused by mutation of the A18
transcript release factor. Second, G2 mutants are depen-
dent upon the anti-poxviral drug isatin-b-thiosemicarba-
zone (IBT) for growth (Meis and Condit, 1991). Although
the exact mechanism of action of IBT is unknown, treat-
ment of wildtype (wt) virus infections with IBT induces a
phenotype identical to an A18 mutant infection, indicat-
ing that IBT promotes read-through transcription in a wt
virus infection (Bayliss and Condit, 1993; Pacha and
Condit, 1985). Theoretically, IBT compensates for a G2
mutation by causing elongation of the 39 truncated G2
mutant RNAs, hence the IBT dependence of G2 mutants.
Theoretically, selection of new extragenic suppressors of
A18 temperature-sensitive mutants or new IBT-depen-
dent (IBTd) mutants should reveal any viral genes in
addition to G2 that might affect viral transcription elon-
gation.
In this report, we describe isolation of one new extra-
genic suppressor of gene A18 and nine new IBTd mu-
tants. Marker rescue mapping and DNA sequence anal-
ysis show that the novel extragenic suppressor of Cts23
contains a point mutation in the J3 gene, while each of
the seven new IBTd mutants contains null mutations in
he J3 gene. Interestingly, the J3 protein has previously
een identified as a (nucleoside-29-O-)-methyltrans-
erase and as a processivity subunit for the het-
rodimeric viral poly(A) polymerase (Schnierle et al.,
992). These results provide genetic evidence to suggest
a
shat the vaccinia J3 gene product, like G2, also serves as
positive transcription elongation factor. The accompa-
ying article presents experiments in support of this
onclusion (Xiang et al., 2000).
RESULTS
utant isolation
Isolation of a novel A18-Cts23 extragenic suppressor.
wo published observations show that mutations in the
accinia gene G2 suppress temperature-sensitive muta-
ions in gene A18 (Condit et al., 1996). First, a double-
utant virus (x41), constructed by crossing an IBTd G2
deletion mutant (G2A) with an A18 ts mutant (Cts23), is
viable. Second, selection for phenotypic revertants (ts1)
of A18 ts mutants (Cts23 or Cts22) resulted in isolation of
extragenic suppressor mutations that mapped to gene
G2. When segregated from the ts A18 allele by a test-
cross with wildtype virus, the suppressing G2 alleles
display an IBTd phenotype. Based on these results, we
hypothesized that mutations in other genes that influ-
ence transcription elongation might be isolated by se-
lecting for novel extragenic suppressors of Cts23.
To isolate new extragenic suppressors of the A18
temperature-sensitive mutant Cts23, the mutant, which
normally grows at 31°C and is sensitive to IBT, was
plated at the nonpermissive temperature (40°C) in the
absence of IBT. Several spontaneous revertant viruses
formed plaques at 40°C. Twenty of these plaques were
picked and tested directly for plaque formation at both 31
and 40°C in the presence and in the absence of IBT. In
this test, one of these viruses, r51, displayed a plaque
phenotype distinct from either wildtype or Cts23, sug-
gesting that r51 might be an extragenic suppressor
rather than a true revertant. Specifically, r51 formed
smaller than wildtype plaques at both 31 and 40°C and
was IBT sensitive. r51 was replaque-purified and grown
for further analysis.
Based on previous experience with G2 suppressors of
Cts23, we hypothesized that the putative suppressor
mutation in r51 might result in IBT dependence when
separated from the Cts23 mutation. To test this hypoth-
sis, r51 was crossed with wt virus to generate recom-
inants that contained either the Cts23 allele or the
utative suppressing allele, but not both. Virus contain-
ng the putative suppressor alone should be readily de-
ectable in a plaque assay of recombinant progeny done
n the presence of IBT since both wt and r51 are IBT
ensitive. To generate recombinants, BSC40 cells were
oinfected with wt virus and r51 at a multiplicity of infec-
ion (m.o.i.) of 6 each and infections were incubated at
0°C without IBT for 48 h. Wildtype and r51 single infec-
ions were done in parallel at an m.o.i. of 12 as controls.
he lysates were then titered in the presence and in the
bsence of drug at both 31 and 40°C to detect the
uspected IBTd phenotype; plaque assays of stocks of
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347VACCINIA GENE J3 MUTANT ISOLATIONCts23 and G2A were done in parallel as controls (Table
1). The results of this experiment show that, relative to
single infections with wt virus or r51, the mixed infection
contained a high proportion of virus that formed plaques
in the presence of IBT, indicating that an IBT variant had
been produced in the cross. To determine the phenotype
of these IBT variants, 10 plaques that grew in the pres-
ence of IBT at 40°C were picked and titered with and
without IBT at both 31 and 40°C. The results showed that
all 10 viruses were IBT dependent for growth at both 31
and 40°C. One IBTd isolate, named r51x4, was replaque-
purified, grown, and subjected to further characteriza-
tion.
The IBTd mutation in r51x4 was mapped by marker
rescue with wildtype DNA fragments as previously de-
scribed (Meis and Condit, 1991; Thompson et al., 1989).
Coarse mapping was first accomplished using a two-
step rescue protocol. BSC40 cells were infected with
r51x4 at an m.o.i. of 0.01 and transfected individually with
cosmid clones containing wildtype vaccinia sequences
that span the entire genome in an overlapping fashion.
The infection–transfections were incubated at 37°C in
the absence of drug until a complete cytopathic effect
was observed. The lysates were then harvested and
titered in the absence of IBT at 37°C (data not shown).
Three overlapping cosmid clones, pWR45-83, pWR67-98,
and pWR74-111 (Fig. 1), were able to rescue the IBT-
dependent phenotype, thus localizing the IBTd mutation
n r51x4 to a region spanning the HindIII J fragment.
ubsequent two-step marker rescue experiments (data
ot shown) with transfected HindIII J fragment subclones
J7 and pJ3R (Fig. 1), the latter of which contains the
recise J3 coding sequence, showed that the IBT depen-
TABLE 1
Test-Cross of r51
Virus infectionb
Titera
31°C 40°C
2IBT 1IBT 2IBT 1IBT
wt 4.0 3 106 ,1.0 3 102 4.0 3 106 1.0 3 103
r51 2.0 3 106 ,1.0 3 101 2.0 3 106 ,1.0 3 101
wt 1 r51 7.0 3 106 8.0 3 105 7.0 3 106 1.6 3 106
G2A ,1.0 3 103 1.0 3 107 2.0 3 103 1.5 3 107
ts23 3.0 3 108 4.0 3 104 3.6 3 105 ,1.0 3 103
a Virus stocks (G2A and Cts23) or lysates from high m.o.i. infections
all others) were plaque titrated under the indicated conditions.
b Rows labeled G2A and Cts23 represent control plaque assays done
on stocks of virus grown under appropriate permissive conditions. For
all other rows, cells were infected at high m.o.i. with the indicated
viruses, and lysates were prepared as described under Materials and
Methods.ence mutation mapped to the J3 open reading frame.
equence analysis of the J3 gene revealed that r51x4
acontains two missense mutations (Fig. 1). The upstream
mutation exchanges a glycine for an aspartic acid resi-
due at codon 96 (G96D). The second mutation is located
in the downstream region of J3 that overlaps the J4 open
reading frame. This mutation results in the exchange of
an arginine for a lysine at codon 327 (R327K) in the J3
gene and the substitution of an asparagine for aspartic
acid at codon 22 (D22N) of the J4 gene. To determine
which of the two mutations was responsible for the IBTd
phenotype, a final one-step marker rescue experiment
was performed with the pJ5 and pJ6 subclones that
contain sequence surrounding the G96D and R327K mu-
tations, respectively. BSC40 cells were infected with
r51x4 at a low m.o.i., transfected with DNA, incubated for
4 days at 40°C in the absence of drug, and stained
directly with crystal violet (Fig. 1). Subclone pJ6 failed to
rescue, thereby demonstrating that the R327K mutation
played no role in the IBTd phenotype. Conversely, the pJ5
ubclone rescued IBT dependence in r51x4, implicating
he G96D mutation as the IBTd allele and also suggesting
hat it is responsible for the suppression of A18-Cts23.
dditional genetic experiments described below were
erformed to verify the conclusions drawn from these
esults.
Creation of the J3x single-mutant virus. A virus con-
aining only the upstream G96D mutation was generated
o confirm that this mutation was solely responsible for
he IBT-dependent phenotype. In order to segregate the
96D mutation from the downstream R327K mutation,
51x4 was crossed to wt virus and the progeny were
creened by PCR and restriction fragment length poly-
orphism (RFLP) analysis. Specifically, BSC40 cells
ere coinfected with r51x4 at an m.o.i. of 3 and wt at an
.o.i. of 15 and then incubated at 37°C for 72 h in the
bsence of drug. The lysates were then harvested and
itered at 37°C in the presence and in the absence of IBT.
wenty plaques that grew in the presence of IBT were
icked and grown, and viral DNA was isolated and sub-
ected to RFLP analysis as follows. Wildtype sequence
panning codon 96 of the J3 gene contains and EagI
estriction site that is removed by the G96D mutation.
imilarly, wildtype sequence spanning codon 327 of the
3 gene contains a BstYI restriction site that is removed
y the R327K mutation. The regions surrounding both
utations were PCR-amplified from the 20 candidate
iruses and the products were digested with the appro-
riate enzyme (data not shown). One of the 20 virus
solates appeared to contain only the G96D mutation
ccording to restriction digestion. This virus was plaque-
urified and sequence analysis of the entire J3 gene
onfirmed that it contained only the G96D mutation. The
ingle mutant was designated J3x and was used for
urther characterization.
Creation of J3x23. The final step in the genetic char-cterization of the J3x virus was to formally prove that the
G96D mutation in J3 suppresses the Cts23 mutation in
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348 LATNER ET AL.A18 by creating a double-mutant virus in a cross be-
tween Cts23 and J3x. BSC40 cells were coinfected with
J3x and Cts23 at m.o.i. of 2.5 each and incubated at 31°C
or 72 h. The lysate was titered at 31 and 40°C in the
resence and in the absence of IBT. Plaques that grew at
0°C in the absence of drug were picked and screened
or the presence of G96D by PCR and restriction diges-
ion as described above. A recombinant virus that con-
ained the G96D mutation was shown by sequence anal-
sis to also contain the A18-Cts23 mutation and was
esignated J3x23. We conclude from these experiments
hat the G96D mutation in J3 is responsible for the IBTd
phenotype and that it serves as an extragenic suppres-
sor of A18-Cts23.
Isolation of IBT-dependent mutants. Given that previ-
FIG. 1. Marker rescue mapping of the IBTd allele in r51x4. Cells were
t DNA clones, incubated at 40°C in the presence of IBT for 5 days
ignificantly above the -DNA background, indicates marker rescue. T
pWR. . .) that rescue r51x4; a HindIII map of the vaccinia genome; a blo
indIII J fragment genes (J1R–J6R) represented as arrows; r51x4 mutatio
etails with wt sequence at the left of each arrow and r51x4 sequence
osition of HindIII J fragment subclones used in the marker rescue, anously characterized mutants of the G2 gene are depen-
dent upon IBT for growth, we attempted to identify addi-tional genes encoding transcription elongation factors by
selecting for novel spontaneous IBT-dependent mutants.
Wildtype virus was plaqued at 37°C in the absence of
drug and 10 well-isolated plaques were picked and
grown to create working stocks. This step was per-
formed to ensure that any mutants derived from these wt
stocks would not be related to one another. The 10 wt
lysates were then titered in the presence and in the
absence of IBT at 37°C. In each of the 10 wt stocks,
several spontaneous mutant viruses that formed plaques
in the presence of IBT were observed. For each of the 10
original wt stocks, 10 plaques that grew in the presence
of drug were picked, giving a total of 100 viruses capable
of growing in the presence of IBT. Next, these 100 viruses
were plaqued in the presence and in the absence of drug
d with r51x4 at an m.o.i. of 0.01 PFU/cell, transfected with the indicated
then stained with crystal violet. The presence of plaques on a dish,
re shows, from the top down: map positions of three cosmid clones
striction map of the HindIII J fragment (H, HindIII; Hc, HincII; Bg, BglII);
resented as vertical lines leading to sequence details; r51x4 sequence
right, J3 sequence above the DNA sequence and J4 sequence below;
tal violet stained dishes from the rescue experiment.infecte
, and
he figu
w-up re
ns rep
at theto determine whether they were resistant to or depen-
dent upon IBT for growth. At least one IBT-dependent
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349VACCINIA GENE J3 MUTANT ISOLATIONvirus isolate was identified from 9 of the 10 original wt
virus stocks. One IBT-dependent plaque arising from
each of these 9 wt stocks was chosen for in-depth study.
The mutation in each IBT-dependent virus was mapped
by marker rescue in a fashion similar to J3x and the
region containing the mutation was sequenced. The re-
FIG. 4. Plaque phenotype of mutant viruses. Confluent monolayers of
SC40 cells in 60-mm dishes were infected with an appropriate dilution
f virus and incubated in the presence or in the absence of IBT under
n agar overlay for 6 days. Dishes were stained overnight with a
econd neutral red containing agar overlay. Agar was then removed
nd cells were stained with crystal violet. The mutant used for infection
s indicated at the left of each row. Each column is labeled at the top to
how the temperature of incubation (31, 37, or 40°C) and whether or not
BT was included (1 or 2).sults, summarized in Tables 2 and 3, show that two of the
mutants contain deletions in gene G2 and seven of themutants contain alterations in gene J3. G2-5 contains a
3-nucleotide in-frame deletion that removes a valine from
position 105 of the G2 gene. G2-2 contains a single base
deletion that results in a frameshift at codon 209 and a
premature termination, yielding a truncated polypeptide
213 amino acids in length. All of the IBT-dependent J3
mutants contain insertions, deletions, or nonsense mu-
tations that result in truncation of the protein significantly
from its wt length of 333 amino acids. Interestingly, each
of the J3 insertion and deletion mutations is located in a
region of the coding sequence that contains a long
stretch of A or T residues (Fig. 2). Presumably, these hot
spots for deletion and insertion arise from slipped mis-
pairing during DNA replication (Streisinger et al., 1966).
ne of the J3 mutant viruses, J3-7, was chosen for further
haracterization. J3-7 contains a single base deletion at
odon 49, resulting in a frameshift and a truncation of the
rotein to 58 amino acids in length. In summary, these
esults confirm that, like G2, null mutation of gene J3
esults in IBT dependence and by analogy with G2 indi-
ates that the J3 gene plays a role in the regulation of
ostreplicative transcription elongation during vaccinia
irus infection.
TABLE 2
G2 IBTd Mutants
Isolate Mutationa Proteinb
Wildtype wt wt; 220 aa
G2-5 Deletion (3) V105D; 219 aa
G2-2 Deletion (1) fs 209; 213 aa
a The number of nucleotides affected by each mutation is included in
arentheses.
b “fs-#” indicates the codon within which a frameshift occurs. “D”
indicates deletion.
TABLE 3
J3 IBTd Mutants
Isolate Mutationa Proteinb
Wildtype wt wt; 333aa
J3-1 Insertion (1) fs 50; 50aa
J3-3 Insertion (1) fs 50; 50aa
J3-4 Nonsense W183*; 182aa
J3-7 Deletion (1) fs 49; 58aa
J3-8 Insertion (1) fs 34; 50aa
J3-9 Nonsense S5*; 4aa
J3-10 Deletion (1) fs 235; 246aa
a The number of nucleotides affected by each mutation is included in
arentheses.b “fs-#” indicates the codon within which a frameshift occurs.
* Indicates a stop codon.
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350 LATNER ET AL.Analysis of mutants
Western blot analysis of A18, J3, and G2 proteins in
mutant infections. Western blot analysis was performed
to confirm predictions derived from sequence data re-
garding expression of the A18, G2, and J3 proteins in
each mutant virus infection (Fig. 3). Infected cell lysates
were electrophoresed through 8% SDS polyacrylamide
gels and transferred to nitrocellulose. The blots were
simultaneously probed with anti-A18, anti-G2, and anti-J3
antibodies and developed by chemiluminescence. All
three proteins are readily apparent in wildtype virus
lysates. Cts23 makes all three proteins, but the relative
mount of A18 protein is reduced, consistent with previ-
us results (Simpson and Condit, 1994). The G2A control
irus encodes a frameshift in the G2 gene and, as pre-
iously described (Black et al., 1998), fails to produce G2
rotein. The J3x missense mutant produces detectable J3
rotein while the other IBT-dependent J3 truncation mu-
FIG. 2. Sequence context of J3 deletion and insertion mutations.
Sequence of J3 insertion and deletion mutants from three different
regions of the J3 gene are compared in each case to wt sequence. The
number to the left of the sequence is the number of the first nucleotide
in the sequence, setting the A in the J3 ATG initiation condon as 11.
Dots have been inserted into either wt or mutant sequence to facilitate
alignment as necessary.
FIG. 3. Western blot analysis of A18, J3, and G2 proteins synthesized
on SDS–PAGE, proteins were transferred to membranes, and membra
developed by chemiluminescence as described under Materials and Methods
left. The identity of the mutant virus used for infection is shown at the top. Thants, J3-1, J3-3, J3-4, J3-7, J3-8, J3-9, and J3-10, produce no
bservable J3 protein. No G2 protein was observed in
2-2, which is missing a valine from position 105, or in
2-5, which has a frameshift truncation of the C-terminal
1 amino acids of the G2 protein, indicating that these
utant proteins are unstable. A18, J3, and G2 proteins
re all detectable in the J3x23 double-mutant but at very
ow levels, presumably because this particular virus
rows poorly and is therefore present in the lysate at a
ow concentration. In addition, the relative amount of A18
rotein in the J3x23 lysate is low, consistent with the
resence of the Cts23 mutation in this virus. In summary,
he results of the Western blot analysis are consistent
ith the DNA sequence analysis of these viruses, show-
ng that the J3 protein of the J3x mutant is stable and that
he new IBTd J3 and G2 mutants produce no detectable
J3 or G2 protein.
Plaque assay. Plaque phenotypes of the J3x, J3x23,
and J3-7 viruses are compared to parental viruses in the
assay shown in Fig. 4. Wildtype virus forms large plaques
at 37°C and intermediate-sized plaques at 31 and 40°C
and is IBT sensitive. Cts23 is both temperature sensitive
and IBT sensitive. r51, the phenotypic revertant of Cts23
and parent of J3x, is ts1 and IBT sensitive, but forms
smaller than wt plaques at both 31 and 40°C. J3x is IBT
dependent and phenotypically identical to its parent
r51x4 (data not shown), confirming that the downstream
J3 R327K mutation in r51x4 does not contribute to the J3x
mutant plaque phenotype. J3x forms larger plaques at
37°C relative to 31 and 40°C, but is somewhat leaky with
respect to IBT dependence at both 31 and 37°C. J3x23 is
phenotypically identical to r51, confirming that the J3
G96D mutation in J3x is sufficient to suppress Cts23 and
that the downstream J3 R327K mutation in r51 does not
contribute to the plaque phenotype of r51. J3-7, which
contains a frameshifting deletion of the J3 gene, has a
noticeably different phenotype when compared to the
point mutant J3x virus. J3-7 forms smaller plaques than
J3x at 37°C and is tighter with respect to IBT dependence
at 37°C. Since J3-7 is likely to be a null mutant, this
observation suggests that the J3x virus may retain some
J3 activity that contributes to its growth phenotype.
wt and mutant infections. Infected cell lysates were electrophoresed
re probed simultaneously with anti-A18, anti-J3, and anti-G2 sera andduring
nes we. The migration of molecular mass standards, in kDa, is shown at the
e migration of the specific protein detected is shown at the right.
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351VACCINIA GENE J3 MUTANT ISOLATIONOne-step growth. To characterize the growth pheno-
types of each virus in more detail, one-step growth ex-
periments were performed. BSC40 cells were infected at
an m.o.i. of 10 with wt, Cts23, or J3-7 or at an m.o.i. of 5
with J3x23. The infections were incubated under permis-
ive and nonpermissive conditions appropriate for each
irus, harvested at various times postinfection, and then
itered under permissive conditions appropriate for each
irus (Fig. 5). Wildtype virus growth was compared to J3x
rowth at 40°C in the presence and in the absence of IBT
FIG. 5. One-step growth analysis of J3 mutant viruses. Confluent m
ndicated at a m.o.i. of 10 for wt, Cts23, J3x, and J3-7 or at a m.o.i.
conditions of temperature (31, 37, or 40°C) in the presence or in the ab
were harvested and plaque titrated under permissive conditions appro
37°C 1 IBT; J3x23, 40°C 2IBT. In each panel, numerical data are pres
J3x is compared to wt. (B) J3-7 is compared to wt. Note in the bar graph
of the mutant data. (C) J3x23 is compared to wt and Cts23.Fig. 5A). At 40°C, wildtype virus yielded 1–5 PFU/cell,
ignificantly higher than the T0 background, and growth
d
oas inhibited by IBT. J3x produced only background
evels of progeny in the absence of IBT and approxi-
ately 1 PFU/cell in the presence of drug, slightly higher
han background. This result confirms and extends the
laque assay, showing that J3x is IBT dependent and
ifficult to grow to high titer. J3-7 growth was compared
o wildtype at 37°C in the presence and in the absence
f IBT (Fig. 5B). Wildtype grew to very high titer in the
bsence of drug, and growth was inhibited by IBT. J3-7
ielded less than 1 PFU/cell at 37°C in the absence of
ers of BSC40 cells in 35-mm dishes were infected with the viruses
or J3x23. Infections were incubated in liquid medium under varying
f IBT (1 or 2) and harvested at 0, 48, and 72 h, as indicated. Lysates
or each virus: wt, 37°C 2IBT; Cts23, 31°C 2IBT, J3x, 40°C 1 IBT; J3-7,
t the left, and bar graphs of the same data are shown on the right. (A)
at the wt data have been truncated at 2 PFU/cell to aid in visualizationonolay
of 5 f
sence o
priate f
ented arug and slightly greater than 1 PFU/cell in the presence
f IBT, indicating that under one-step growth conditions
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352 LATNER ET AL.J3-7 is moderately IBT dependent and confirming that,
like J3x, it is also difficult to grow. The growth of J3x23
was compared to wt and Cts23 at both 31 and 40°C in
the absence of IBT. Both wt and Cts23 produced 4–10
PFU/cell at 31°C, but Cts23 produced only background
evels of virus at 40°C, consistent with plaque assay
esults. J3x23 generated 0.5–1 PFU/cell at both temper-
tures, which is higher than background, but less than
ildtype. These results confirm that the J3x mutation
uppresses Cts23 and show that J3x23 grows very
oorly. In summary, these experiments show that the
ne-step growth properties of all three mutant viruses
re generally consistent with the plaque assay pheno-
ype and that the mutant viruses all grow poorly under
ermissive conditions.
DISCUSSION
Based on previous phenotypic analysis of mutants in
he vaccinia virus G2 postreplicative positive transcrip-
ion elongation factor, we have used two independent
enetic selections to search for additional vaccinia
enes involved in the regulation of viral transcription
longation. In one selection, we isolated nine viruses
ontaining spontaneous mutations that render the vi-
uses dependent upon the anti-poxviral drug IBT for
rowth. Consistent with previous results (Meis and Con-
it, 1991), two of these mutants have defects in the G2
longation factor. Mutations in the other seven IBTd se-
ected viruses mapped to the J3 gene. In the second
election an additional J3 gene mutant, J3x, was isolated
s an extragenic suppressor of the Cts23 mutation in the
18 transcript release factor. By analogy with previous
haracterization of the G2 gene (see Introduction), these
esults suggest that the J3 gene is a postreplicative
ositive transcription elongation factor.
Interestingly, the vaccinia J3 gene product has been
reviously characterized as a bifunctional protein con-
aining both poly(A) polymerase stimulatory and (nucle-
side-29-O-)-methyltransferase activities (Schnierle et al.,
992). The vaccinia virus coded poly(A) polymerase is a
eterodimer, comprising the 55-kDa E1 protein com-
lexed with the 39-kDa J3 protein (Gershon et al., 1991).
he E1 subunit contains the adenylyltransferase active
ite, and E1 by itself can processively add only 30–35
denylate residues to a nascent mRNA 39 end (Gershon
nd Moss, 1993). The J3 protein binds both the E1 protein
nd poly(A) and stimulates the E1 protein to add addi-
ional adenylate residues in a semiprocessive fashion to
uild poly(A) tails averaging approximately 150 nt in
ength (Gershon and Moss, 1992). The J3 (nucleoside-29-
-)-methyltransferase activity methylates the ribose of
he first transcribed base of the 59 cap structure on
essenger RNAs, converting a cap-0 structure to a cap-1tructure (Barbosa and Moss, 1978a,b). During infection,
he J3 protein is expressed in fivefold molar excesselative to the E1 protein, and the (nucleoside-29-O-)-
ethyltransferase activity is present in both the mono-
eric and the heterodimeric forms of the protein (Ger-
hon et al., 1991; and E. Niles personal communication).
The results reported here suggest a third activity for the
J3 protein, specifically a positive postreplicative tran-
scription elongation factor activity, raising the interesting
question of whether either of the previously character-
ized J3 protein functions is related to the putative tran-
scription elongation function.
The nature of the newly isolated mutations in the J3
gene provides clues to the relationship between the
putative J3 elongation factor activity and the previously
described poly(A) polymerase stimulatory and (nucleo-
side-29-O-)-methyltransferase activities. Both DNA se-
quence and Western blot analyses of the seven new J3
mutants selected initially for IBT dependence show that
these are null mutants: each contains a chain-terminat-
ing nonsense or frameshift mutation, and none synthe-
sizes detectable J3 protein. Thus all of these seven
mutants should be lacking in both poly(A) polymerase
stimulatory and (nucleoside-29-O-)-methyltransferase ac-
tivities. By contrast, J3x, which was initially isolated as a
Cts23 suppressor but which is also IBT dependent, con-
tains a missense mutation (G96D) that does not affect
the steady state levels of J3 protein produced during
infection. Under permissive conditions J3x forms larger
plaques than a representative J3 null mutation (J3-7),
suggesting that the J3x mutant may retain some J3 pro-
tein function. Interestingly, the published crystal struc-
ture of J3 shows that the J3x G96D missense mutation is
localized very near the methyltransferase active site of
the J3 protein, between a highly conserved aspartic acid
at position 95 and an arginine at position 97, both of
which form hydrogen bonds with the methyl donor S-
adenosylmethionine (Hodel et al., 1996). Thus if the J3x
protein is missing either of the previously identified J3
activities, it seems most likely that it would be defective
in methyltransferase and retain poly(A) polymerase stim-
ulatory activity. This hypothesis is tested in the accom-
panying article (Xiang et al., 2000).
The two different selections described, IBT depen-
dence and Cts23 suppression, may discriminate the two
different types of J3 mutants isolated. Specifically, selec-
tion for IBT dependence resulted in isolation entirely of
null J3 mutants, while selection of Cts23 resulted in
isolation of the more subtle J3x missense mutation,
which, as described above, may retain some J3 protein
activity. It is noteworthy in this regard that while mutation
of J3 suppresses Cts23 as judged by plaque formation,
the resulting double-mutant virus grows extremely
poorly, as judged by one-step growth. Since J3 null mu-
tants are more defective in growth than J3x, it seems
likely that null mutation of J3, while it may compensate
for the effects of Cts23, would leave a double-mutant
virus too crippled to grow at all, thus prohibiting isolation
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353VACCINIA GENE J3 MUTANT ISOLATIONof J3 null mutant suppressors of Cts23. Consistent with
this idea, we have been unsuccessful in several attempts
to construct a J3-7, Cts23 double-mutation by recombi-
nation.
By contrast with the J3 gene, our results show that null
mutants of the G2 gene can suppress ts mutants in A18,
including both Cts23 and Cts22. Specifically, previous
results show that a frameshifting deletion in G2 can
suppress Cts23 (Condit et al., 1996). We have also per-
formed Western blot analysis on three previously iso-
lated G2 point mutant suppressors of Cts23 and Cts22
(r41, cs1, and cs4) and determined that none of these
mutants produce detectable G2 protein (D. Latner, un-
published observations). These observations could sug-
gest that the G2 gene has a more limited range of
function than the J3 gene, such that a knockout of the G2
function can be tolerated in the presence of an A18 gene
mutation.
In summary, based on the genetic analysis reported
here, we hypothesize that the J3 gene product, a
bifunctional (nucleoside-29-O-)-methyltransferase and
poly(A) polymerase processivity factor, is also a posi-
tive postreplicative transcription elongation factor.
Phenotypic analysis of J3 mutant viruses and biochem-
ical analysis of the J3x protein presented in the ac-
companying article (Xiang et al., 2000) provides sup-
port for this hypothesis.
MATERIALS AND METHODS
Cells and virus
The conditions for culturing BSC40 African green mon-
key kidney cells and methods for vaccinia virus cultiva-
tion, infection, plaque assay, and one-step growth have
been previously described (Condit et al., 1983; Condit
and Motyczka, 1981). The wildtype vaccinia virus strain
WR, the A18 mutant Cts23, and the G2 mutant G2A have
been previously described (Condit et al., 1983; Condit
and Motyczka, 1981; Meis and Condit, 1991). In short,
Cts23 was isolated as a temperature-sensitive virus that
arose from random nitrosoguanidine mutagenesis of
wildtype virus. G2A contains an engineered 10-bp dele-
tion in gene G2, resulting in a frameshift at codon 90 and
truncation of the 220-amino-acid protein at position 93.
IBT was prepared fresh before each use and applied at
a final concentration of 45 mM as previously described
Pacha and Condit, 1985).
NA sequence analysis
Sequence of mutant virus DNA was obtained by se-
uencing PCR products amplified from genomic DNAhat was isolated by one of two different methods: (1)
NA was isolated as described except the amountsere scaled down 20-fold (Esposito et al., 1981). (2)
iagen DNeasy miniprep spin columns (Qiagen Inc.,
anta Clarita, CA) were utilized to purify total infected
ell DNA from 200 ml of infected cell lysate following the
anufacturer’s instructions for isolating DNA from cells
n culture.
The complete J3 coding sequence was PCR-amplified
ith two primers that hybridize just outside of the open
eading frame and yield a 1197-bp product. Sequence
as obtained from both strands of DNA with the same
rimers used for amplification and with two additional
rimers that hybridize in the middle of the coding se-
uence to give overlapping products. Sequencing was
erformed by the University of Florida Interdisciplinary
enter for Biotechnology Research DNA Sequencing
ore Laboratory.
FLP analysis
The screen for the J3x single-mutant virus from the
r51x4 test-cross was performed by restriction fragment
length polymorphism analysis of two different PCR
products generated from virus genomic DNA. Candi-
date mutant plaques were picked and grown, and viral
genomic DNA was prepared as described above. A
379-bp PCR product that spanned the G96D upstream
mutation was amplified with appropriate primers and
then digested with EagI. A downstream 522-bp PCR
product that spanned the mutation in the J3/J4 over-
lapping region (J3:R327K/J4:D22N) was amplified with
appropriate primers and then digested with BstYI. Re-
striction fragments were analyzed on 1% MetaPhor
agarose (FMC BioProducts, Rockland, ME) in TBE.
Both restriction enzymes cleave wildtype sequence
but not mutant sequence. A mutant virus was identi-
fied that was resistant to EagI in the 379-bp upstream
PCR product but sensitive to BstYI in the downstream
522-bp PCR product. Subsequent sequence analysis
of the entire J3 open reading frame confirmed the
presence of the upstream mutation and absence of the
downstream mutation. The single-mutant virus was
designated J3x and was utilized for further character-
ization.
DNA clones and marker rescue
Marker rescue was performed as previously de-
scribed (Meis and Condit, 1991; Thompson and Condit,
1986). The cosmid clones used for initial marker rescue
experiments have been previously characterized
(Thompson and Condit, 1986). The J fragment subclones
pJ5, pJ6, and pJ7 (Fig. 1) were generously supplied by
Jerry Weir and have been described (Ensinger et al.,
1985). The clone pJ3R, which contains the precise J3
open reading frame cloned in pET14b, was a gift from Ed
Niles (SUNY Buffalo).
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354 LATNER ET AL.Western blot analysis
One hundred twenty-five microliters of virus lysate was
combined with 250 ml of SDS–PAGE sample buffer.
Thirty-five microliters of each sample was electropho-
resed on an 8% polyacrylamide–SDS gel and then the
proteins were transferred from the gel to nitrocellulose in
25 mM Tris base, 192 mM glycine, 20% methanol for 3 h
at 4°C and 80 V. The membrane was blocked with 5% dry
milk in PBS for 1.5 h, washed three times for 5 min with
0.05% NP-40 in PBS, and incubated for 1 h with anti-A18,
anti-G2, and anti-J3 primary antibodies diluted 1:10,000,
1:1000, and 1:5000, respectively, in PBS plus 5% dry milk.
The monoclonal anti-A18 and anti-G2 antibodies have
been previously described (Black and Condit, 1996). The
rabbit polyclonal anti-J3 antibody was a gift from Ed Niles
(SUNY Buffalo). The blot was then washed three times
for 5 min with 0.05% NP-40 in PBS and incubated with
secondary HRP-conjugated anti-rabbit and anti-mouse
antibodies diluted 1:10,000 and 1:5000, respectively, for
1 h. The blot was washed three times for 10 min with PBS
plus 0.05% NP-40 and once for 2 min in PBS. Final
detection was performed with an ECL Western detection
kit (Amersham Pharmacia) according to the manufac-
turer’s instructions.
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